Browsing by Author Rawling, T

Showing results 1 to 20 of 32  next >
Issue DateTitleAuthor(s)
1-Jul-2019l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's diseaseBillings, JL; Gordon, SL; Rawling, T; Doble, PA; Bush, AI; Adlard, PA; Finkelstein, DI; Hare, DJ
14-Mar-2019Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 to Produce Analgesia in a Rat Model of Chronic PainMostyn, SN; Rawling, T; Mohammadi, S; Shimmon, S; Frangos, ZJ; Sarker, S; Yousuf, A; Vetter, I; Ryan, RM; Christie, MJ; Vandenberg, RJ
1-Mar-2019Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cellsAl-Zubaidi, Y; Pazderka, C; Koolaji, N; Rahman, MK; Choucair, H; Umashankar, B; Bourget, K; Chen, Y; Rawling, T; Murray, M
13-Oct-2018Nanoemulsion-enabled oral delivery of novel anticancer ω-3 fatty acid derivativesPereira, GG; Rawling, T; Pozzoli, M; Pazderka, C; Chen, Y; Dunstan, CR; Murray, M; Sonvico, F
1-Jun-2018Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cordWinters, BL; Rawling, T; Vandenberg, RJ; Christie, MJ; Bhola, RF; Imlach, WL
23-May-2018Carboxylate Analogues of Aryl-Urea-Substituted Fatty Acids That Target the Mitochondria in MDA-MB-231 Breast Cancer Cells to Promote Cell DeathKoolaji, N; Rawling, T; Bourget, K; Murray, M
1-Mar-2018Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liverMurray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T
26-Oct-2017A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin to Promote Killing of Breast Cancer CellsRawling, T; Choucair, H; Koolaji, N; Bourget, K; Allison, SE; Chen, YJ; Dunstan, CR; Murray, M
20-Sep-2017Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2Mostyn, SN; Carland, JE; Shimmon, S; Ryan, RM; Rawling, T; Vandenberg, RJ
1-Jan-2017Antiproliferative activities of alkaloid-like compoundsXu, X; Rawling, T; Roseblade, A; Bishop, R; Ung, AT
1-Jan-2017A novel synthetic analogue of v-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ ASK1/JNK signaling to promote apoptosis in human breast cancer cellsDyari, HRE; Rawling, T; Chen, Y; Sudarmana, W; Bourget, K; Dwyer, JM; Allison, SE; Murray, M
6-Nov-2016Alkaloid-like Molecules for Drug DiscoveryWilliams, SG; Rawling, T; Ung, AT
1-Jun-2015Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugsMurray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T
1-Nov-2014Selective inhibition of human solute carrier transporters by multikinase inhibitorsJohnston, RA; Rawling, T; Chan, T; Zhou, F; Murray, M
17-Dec-2013Cell-derived microparticles: New targets in the therapeutic management of diseaseRoseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M
1-Jan-2013Anti-proliferative actions of N0-desmethylsorafenib in human breast cancer cellsCui, PH; Rawling, T; Gillani, TB; Bourget, K; Wang, XS; Zhou, F; Murray, M
29-Jul-2012Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: Kinetics and applicationRawling, T; McDonagh, AM; Tattam, B; Murray, M
15-Jul-2012Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolitesGhassabian, S; Rawling, T; Zhou, F; Doddareddy, MR; Tattam, BN; Hibbs, DE; Edwards, RJ; Cui, PH; Murray, M
1-Jan-2012Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): Structure-based design of MKP-1 inhibitors and upregulatorsDoddareddy, MR; Rawling, T; Ammit, AJ
1-May-2011Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MSAustin, C; Fryer, F; Lear, J; Bishop, D; Hare, D; Rawling, T; Kirkup, L; McDonagh, A; Doble, P